Massachusetts General Hospital, Neuroendocrine Unit — Boston, Massachusetts

Massachusetts General Hospital, Neuroendocrine Unit is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital, Neuroendocrine Unit has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Vasopressin Deficiency.

Sponsors: Elizabeth Austen Lawson.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital, Neuroendocrine Unit?

Massachusetts General Hospital, Neuroendocrine Unit has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital, Neuroendocrine Unit conducted?

Massachusetts General Hospital, Neuroendocrine Unit has 1 clinical trials on record, with 1 currently active. Their work covers Vasopressin Deficiency.

Is Massachusetts General Hospital, Neuroendocrine Unit accredited by Crixeo Health?

Massachusetts General Hospital, Neuroendocrine Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital, Neuroendocrine Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.